Measurement of body surface energy leakage of defibrillation shock by an implantable cardioverter defibrillator

被引:3
|
作者
Niwano, S
Kojima, J
Inuo, K
Saito, J
Kashiwa, T
Suyama, M
Toyoshima, T
Aizawa, Y
Izumi, T
机构
[1] Kitasato Univ, Sch Med, Dept Internal Med, Sagamihara, Kanagawa 2288555, Japan
[2] Medtron Japan Co Ltd, Tachy Business Grp, Tokyo, Japan
[3] Medtron Japan Co Ltd, Res & Dev, Tokyo, Japan
[4] Niigata Univ, Sch Med, Dept Internal Med 1, Niigata, Japan
来源
关键词
defibrillation; electrical stimulation; electrical shock; tachyarrhythmias; antitachycardia device;
D O I
10.1046/j.1460-9592.2002.01212.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leakage of electrical current from the body surface during a defibrillation shock delivery by an ICD device was evaluated in 27 patients with life-threatening ventricular tachyarrhythmias. All patients underwent the implantation of the Medtronic jewel Plus ICD system, and the defibrillation shocks were delivered between the active can implanted in the left subclavicular region and the endocardial lead placed in the right ventricle. At the time of measurement of the effect of electrical energy delivery for defibrillation, the shocks were delivered in a biphasic form at the energy level of 20 or 30 J. During each delivery of the defibrillation shock, the electrical current to the body surface was measured through large skin electrodes (6.2 cm(2)) that were pasted at the following positions: (1) parallel position: the electrodes were placed at the left shoulder and the right low-chest, and the direction of the electrode vector was parallel to the direction of the defibrillation energy flow, and (2) cross position: the electrodes were placed at the right shoulder and the left low-chest, and the vector of the electrodes was roughly perpendicular to the direction of the energy flow. The energy leakages were measured in 80 defibrillation shocks. The peak leakage current during the shock delivery at energy of 30 J was 48 +/- 26 mA at the parallel position and 19 +/- 15 mA at the cross position (P = 0.0002). The energy leakage at a 30-J shock was 7.4 +/- 7.2 mJ at the parallel position and 1.4 +/- 2.3 mJ at the cross position (P = 0.0002). The actual maximum energy leakage was 105 mA, 29 mJ, and 106 V that appeared at the parallel position. The body surface leakage of the defibrillation energy of the ICD device was evaluated. The power of the energy leakage strongly depended on the angle between the alignment of the recording electrodes and the direction of the energy flow. The highest current leakage to the body surface reached a considerable level, but the energy leakage was small because of the short duration of the defibrillation shock.
引用
收藏
页码:1212 / 1218
页数:7
相关论文
共 50 条
  • [21] Successful defibrillation verification in subcutaneous implantable cardioverter-defibrillator recipients by low-energy shocks
    Biffi, Mauro
    Ziacchi, Matteo
    Angeletti, Andrea
    Castelli, Andrea
    Massaro, Giulia
    Martignani, Cristian
    Lovecchio, Mariolina
    Valsecchi, Sergio
    Diemberger, Igor
    CLINICAL CARDIOLOGY, 2019, 42 (06) : 612 - 617
  • [22] Relation between total shock energy and mortality in patients with implantable cardioverter-defibrillator
    Tenma, Taro
    Yokoshiki, Hisashi
    Mitsuyama, Hirofumi
    Watanabe, Masaya
    Mizukami, Kazuya
    Kamada, Rui
    Takahashi, Masayuki
    Sasaki, Ryo
    Maeno, Motoki
    Okamoto, Kaori
    Chiba, Yuki
    Anzai, Toshihisa
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 259 : 94 - 99
  • [23] Relationship of Shock Energy to Impedance During Subcutaneous Implantable Cardioverter-Defibrillator Testing
    Payne, Joshua E.
    Badertscher, Patrick
    Field, Michael E.
    Sturdivant, J. Lacy
    Gold, Michael R.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2020, 13 (09):
  • [24] Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion
    Hadid, Claudio
    Atienza, Felipe
    Strasberg, Boris
    Arenal, Angel
    Codner, Pablo
    Gonzalez-Torrecilla, Esteban
    Datino, Tomas
    Percal, Tamara
    Almendral, Jesus
    Ortiz, Mercedes
    Martins, Raphael
    Martinez-Alzamora, Nieves
    Fernandez Aviles, Francisco
    CARDIOLOGY JOURNAL, 2015, 22 (03) : 253 - 259
  • [25] Elevation of defibrillation thresholds with propofol during implantable cardioverter-defibrillator testing
    Cohen, TJ
    Chengot, T
    Quan, C
    Peller, AP
    JOURNAL OF INVASIVE CARDIOLOGY, 2000, 12 (02): : 121 - 123
  • [26] Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation
    Leong-Sit, Peter
    Gula, Lorne J.
    Diamantouros, Pantelis
    Krahn, Andrew D.
    Skanes, Allan C.
    Yee, Raymond
    Klein, George J.
    AMERICAN HEART JOURNAL, 2006, 152 (06) : 1104 - 1108
  • [27] Intermuscular Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing
    Mistry, Amar
    Pooranachandran, Vivetha
    Dhutia, Harshil
    Chelliah, Rajesh
    Pathmanathan, Ravi K.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2021, 7 (01) : 124 - 126
  • [28] THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - EFFECT OF PATCH POLARITY ON DEFIBRILLATION THRESHOLD
    ONEILL, PG
    BOAHENE, KA
    LAWRIE, GM
    HARVILL, LF
    PACIFICO, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 17 (03) : 707 - 711
  • [29] Effect of Substance Abuse on Defibrillation Threshold in Patients with Implantable Cardioverter-Defibrillator
    Perrine, Shane A.
    Nayak, Raghavendra
    Bharadwaj, Aditya S.
    Mckelvey, George
    Mohamad, Tamam
    Jacob, Sony
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2011, 34 (02): : 193 - 199
  • [30] Reduction in defibrillation threshold by modifications to the subcutaneous implantable-cardioverter defibrillator coil
    Heist, E. Kevin
    Knops, Reinoud E.
    Yap, Sing-Chien
    Boersma, Lucas V. A.
    Friedman, Daniel J.
    Poole, Jeanne E.
    Stahl, Wyatt
    Belalcazar, Andres
    HEART RHYTHM, 2023, 20 (05) : 783 - 785